UPL and Agrauxine by Lesaffre Announce Agreement to Develop and Commercialize Microbial Bio-control Technology in United States

The exclusive license and supply agreement announced last week will allow UPL, global leader in sustainable agriculture solutions, to commercialize a new biocontrol technology from Agrauxine by Lesaffre in the United States.

UPL is the world’s largest manufacturer and distributor of biosolutions, and last year launched Natural Plant Protection (NPP), a new global business unit championing UPL’s comprehensive portfolio of natural and biologically derived agriculture inputs and technologies. The collaboration with Agrauxine broadens the biological offerings that NPP will deliver in the United States. A new biocontrol technology from the collaboration is awaiting U.S. EPA registration, expected later in 2022.

“Agrauxine is a recognized global innovator in the development of sustainable solutions derived from microorganisms that address critical challenges of growers. This partnership is a natural for us, and it’s a collaboration that will strengthen our BioSolutions product pipeline to deliver enhanced value for U.S. growers.”

Jim Petta, Natural Plant Protection Head, North America.

“We have strong ambitions for growth in the U.S. market. We’re looking forward to our partnership with UPL to deliver this new biocontrol technology derived from microorganisms that will help growers overcome crop stresses during germination, emergence and early plant growth.”

Hugo Bony, CEO of Agrauxine by Lesaffre.

To read the full press release, click here.